Search

Your search keyword '"Coggins, Matthew"' showing total 121 results

Search Constraints

Start Over You searched for: Author "Coggins, Matthew" Remove constraint Author: "Coggins, Matthew"
121 results on '"Coggins, Matthew"'

Search Results

1. Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome (NODRS)

2. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

3. Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly

4. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

5. Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities

6. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

7. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

8. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

9. De novo variants in DENND5B cause a neurodevelopmental disorder

10. Clinical application of a scale to assess genomic healthcare empowerment (GEmS): Process and illustrative case examples

11. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

12. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

13. Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care

14. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

15. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

16. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

17. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

18. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

19. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

20. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

21. De novo variants in DENND5B cause a neurodevelopmental disorder

22. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

23. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

24. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

25. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

26. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

27. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

28. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

29. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

30. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

31. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

32. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

34. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

35. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

36. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

37. Loss-of-function in RBBP5results in a syndromic neurodevelopmental disorder associated with microcephaly

38. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

39. Dominant missense variants in SREBF2are associated with complex dermatological, neurological, and skeletal abnormalities

40. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

41. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

46. Phenotypic Characterization of Individuals With Variants in Cardiovascular Genes in the Absence of a Primary Cardiovascular Indication for Testing

47. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

48. Variants in PRKAR1Bcause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

49. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

50. An autosomal dominant neurological disorder caused by de novo variants in FAR1resulting in uncontrolled synthesis of ether lipids

Catalog

Books, media, physical & digital resources